| Primary |
| Drug Use For Unknown Indication |
34.0% |
| Hypothyroidism |
11.3% |
| Cardiac Failure Congestive |
9.4% |
| Fluid Retention |
7.5% |
| Gout |
7.5% |
| Cardiac Failure |
5.7% |
| Type 2 Diabetes Mellitus |
5.7% |
| Blood Pressure |
3.8% |
| Hypertension |
3.8% |
| Renal Failure Chronic |
3.8% |
| Asthma |
1.9% |
| Cardiomyopathy |
1.9% |
| Oedema |
1.9% |
| Pulmonary Hypertension |
1.9% |
|
| Temporal Arteritis |
17.2% |
| Renal Failure Acute |
13.8% |
| Diverticulum |
6.9% |
| Encephalopathy |
6.9% |
| Balance Disorder |
3.4% |
| Blood Glucose Increased |
3.4% |
| Diabetes Mellitus |
3.4% |
| Drug Ineffective |
3.4% |
| Fluid Retention |
3.4% |
| Hepatocellular Injury |
3.4% |
| Humerus Fracture |
3.4% |
| Medication Error |
3.4% |
| Myalgia |
3.4% |
| Myocardial Infarction |
3.4% |
| Procedural Complication |
3.4% |
| Product Substitution Issue |
3.4% |
| Rash |
3.4% |
| Renal Failure |
3.4% |
| Suicide Attempt |
3.4% |
| Toxic Encephalopathy |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
17.6% |
| Drug Use For Unknown Indication |
15.2% |
| Hypertension |
14.9% |
| Lung Infection |
6.9% |
| Cardiac Failure |
6.6% |
| Arteriosclerosis Obliterans |
5.4% |
| Arteriosclerosis |
4.5% |
| Gout |
3.6% |
| Pulmonary Hypertension |
3.3% |
| Blood Pressure Abnormal |
3.0% |
| Type 1 Diabetes Mellitus |
2.7% |
| Hypothyroidism |
2.1% |
| Oedema |
2.1% |
| Type 2 Diabetes Mellitus |
2.1% |
| Cardiac Failure Chronic |
1.8% |
| Cardiac Failure Congestive |
1.8% |
| Immunosuppression |
1.8% |
| Mineral Supplementation |
1.8% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Renal Failure Chronic |
1.5% |
|
| Renal Failure Acute |
20.3% |
| Gastrointestinal Haemorrhage |
8.5% |
| Temporal Arteritis |
8.5% |
| Thrombocytopenia |
6.8% |
| Urine Abnormality |
5.1% |
| Death |
3.4% |
| Drug Administration Error |
3.4% |
| Drug Hypersensitivity |
3.4% |
| Enterocolitis Infectious |
3.4% |
| Generalised Oedema |
3.4% |
| Hepatotoxicity |
3.4% |
| Hodgkin's Disease |
3.4% |
| Hyponatraemia |
3.4% |
| Hypotension |
3.4% |
| Pain In Extremity |
3.4% |
| Pulmonary Fibrosis |
3.4% |
| Pyrexia |
3.4% |
| Rash |
3.4% |
| Shock |
3.4% |
| Shoulder Operation |
3.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
43.0% |
| Drug Use For Unknown Indication |
25.1% |
| Hypertension |
4.6% |
| Pulmonary Arterial Hypertension |
2.9% |
| Atrial Fibrillation |
2.9% |
| Pain |
2.7% |
| Diabetes Mellitus |
2.1% |
| Chronic Obstructive Pulmonary Disease |
1.6% |
| Cardiac Disorder |
1.5% |
| Cardiac Failure Congestive |
1.5% |
| Depression |
1.5% |
| Type 2 Diabetes Mellitus |
1.4% |
| Prophylaxis |
1.3% |
| Coronary Artery Bypass |
1.3% |
| Fluid Retention |
1.3% |
| Rheumatoid Arthritis |
1.2% |
| Hypothyroidism |
1.1% |
| Multiple Myeloma |
1.0% |
| Gastrooesophageal Reflux Disease |
1.0% |
| Pulmonary Hypertension |
1.0% |
|
| Vomiting |
12.6% |
| Renal Failure |
8.1% |
| Weight Increased |
7.5% |
| Pain |
7.1% |
| Death |
6.9% |
| Weight Decreased |
6.8% |
| Urinary Tract Infection |
6.2% |
| Injury |
4.8% |
| Renal Failure Acute |
4.2% |
| Dyspnoea |
3.8% |
| Oedema Peripheral |
3.8% |
| Nausea |
3.7% |
| Drug Ineffective |
3.4% |
| Transient Ischaemic Attack |
3.4% |
| Tremor |
3.1% |
| Unevaluable Event |
3.1% |
| Pneumonia |
3.0% |
| Rash |
3.0% |
| Sepsis |
2.8% |
| Cardiac Failure Congestive |
2.7% |
|
| Interacting |
| Anticoagulant Therapy |
25.0% |
| Cardiac Disorder |
25.0% |
| Diuretic Therapy |
25.0% |
| Pollakiuria |
25.0% |
|
| Tremor |
40.0% |
| Chest Pain |
20.0% |
| Drug Interaction |
20.0% |
| Joint Swelling |
20.0% |
|
